SBA
ABBV icon

Secrest Blakey & Associates’s AbbVie ABBV Stock Holding History

Secrest Blakey & Associates’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-3,142
Closed -$238K – 62
2019
Q3 		$238K Buy
+3,142
New +$215K 0.2% 89
2019
Q1 		– Sell
-2,380
Closed -$219K – 124
2018
Q4 		$219K Buy
2,380
+20
+0.8% +$1.76K 0.18% 91
2018
Q3 		$223K Buy
2,360
+18
+0.8% +$1.71K 0.17% 95
2018
Q2 		$217K Sell
2,342
-5
-0.2% -$488 0.17% 99
2018
Q1 		$222K Sell
2,347
-133
-5% -$14.6K 0.19% 94
2017
Q4 		$240K Buy
+2,480
New +$234K 0.19% 93

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Secrest Blakey & Associates's ABBV Position: Q4 2019 in Review

Secrest Blakey & Associates sold out of AbbVie (ABBV) in Q4 2019, closing a stake of 3,142 shares — an estimated $238K sold.

Secrest Blakey & Associates first reported a position in ABBV in Q4 2017 and held it in 6 quarters. The position peaked at $240K in Q4 2017. 2,243 funds tracked by Wall St. Rank hold ABBV as of Q4 2019.

  • Secrest Blakey & Associates reported no remaining AbbVie position as of Q4 2019 after selling out during the quarter.
  • Secrest Blakey & Associates sold 3,142 AbbVie shares in Q4 2019, an estimated $238K.
  • Secrest Blakey & Associates first reported a position in AbbVie in Q4 2017 and held it in 6 quarters.
  • Secrest Blakey & Associates's AbbVie position peaked at $240K in Q4 2017.
  • 2,243 funds tracked by Wall St. Rank held AbbVie as of Q4 2019.

Based on Secrest Blakey & Associates's 13F filing for Q4 2019, filed 5 Feb 2020.